Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2025-12-02 Capital/Financing Update
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
(補充公告)代盧森堡子公司Lotus US Financing S.à.r.l.公告實物增資取得有價 證券
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a transaction involving the acquisition of preferred shares by a Luxembourg subsidiary from the parent company. It includes specifics such as transaction dates, prices, parties involved, board approval dates, and accounting firm opinions. The content focuses on a capital transaction and financing activity rather than a financial report, earnings release, or management discussion. The document length is 2555 characters, which is relatively short but contains detailed transaction information rather than just a notice or announcement of a report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2025-12-02 Chinese
公告本公司法人董事代表人異動
Board/Management Information Classification · 100% confidence The document is a short announcement (703 characters) about a change in the company's legal entity director representative, including names, dates, and reasons for the change. It does not contain financial data, audit information, or report content. The key phrase '法人董事代表人異動' translates to 'change in legal entity director representative,' which aligns with announcements about changes in board or senior management. Therefore, this document fits the category of Board/Management Information (MANG).
2025-12-01 Chinese
代子公司Lotus US Financing S.a.r.l.公告現金增資
Capital/Financing Update Classification · 100% confidence The document is a formal announcement from a listed company (1795 美時) regarding a cash capital increase by its subsidiary Lotus US Financing S.a.r.l. It details the board resolution date, amount and number of shares issued, share price, and purpose of the capital increase (investment to acquire full ownership of New Alvogen Group Holding, Inc.). The content focuses on financing activity and capital structure changes. The document length is short (980 characters) and it is not a report but an announcement of a capital increase event. Therefore, it fits the category of Capital/Financing Update (CAP).
2025-11-27 Chinese
代盧森堡子公司Lotus US Financing S.à.r.l.公告實物增資取得有價證券
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a transaction involving the company's Luxembourg subsidiary acquiring securities through a capital increase. It includes specifics such as transaction dates, parties involved, pricing, board approval, and accounting opinions. The content focuses on a capital transaction and related disclosures rather than financial results, management changes, or legal matters. The document length is 2474 characters, which is relatively short but contains substantive transaction details. This fits the definition of a Capital/Financing Update (CAP) rather than a simple announcement or regulatory filing. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2025-11-27 Chinese
公告本公司處分New Alvogen Group Holding, Inc.特別股股權
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from a listed company (1795 美時) regarding the disposal of preferred shares of New Alvogen Group Holding, Inc. to its wholly owned subsidiary. It details the transaction specifics such as share quantities, prices, dates, related parties, and approvals. The document is relatively short (2611 characters) and focuses on a specific capital transaction rather than providing comprehensive financial statements or management discussion. It does not contain financial results, earnings data, or detailed report content. This fits the definition of a Capital/Financing Update (CAP) as it updates on a financing-related transaction involving share disposal and capital structure changes. It is not an announcement of a report publication, nor a full financial report or earnings release.
2025-11-27 Chinese
公告董事會決議通過增資盧森堡子公司 Lotus US Financing S.à.r.l.
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from a listed company (1795 美時) regarding a board resolution to increase capital in its Luxembourg subsidiary, Lotus US Financing S.à.r.l. It details the transaction specifics such as share quantity, price, total amount, and purpose of the capital increase. The document is short (2165 characters) and focuses on a specific financing transaction approved by the board. It does not contain comprehensive financial statements or detailed financial performance data. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2025-11-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.